Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
The antiphospholipid antibodies included as laboratory criteria of the antiphospholipid syndrome (APS) are antibodies reacting with anionic phospholipids - anticardiolipin antibodies and lupus anticoagulant - and with beta(2)-glycoprotein I. However, antibodies reacting with phosphatidylethanolamine (aPE), a zwitterionic phospholipid, have also been described to be associated with the main features of APS. The objectives of this review are to describe the characteristics of aPE and to bring attention to recent evidence that aPE are correlated with the main clinical features of APS, notably, in the absence of the laboratory criteria of this syndrome.
Sanmarco
M
M
Laboratoire d'Immunologie, Hôpital de La Conception, Marseille, France. msanmarco@ap-hm.fr
Boffa
M-C
MC
D000026:Abortion, Habitual / Q000209:etiology; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D010714:Phosphatidylethanolamines / Q000276:immunology*; D013927:Thrombosis / Q000209:etiology
D017152:Antibodies, Antiphospholipid; D010714:Phosphatidylethanolamines; C483858:phosphatidylethanolamine